• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenoxyacetic acid derivatives

Research Brief on 2-Isopropylphenoxy Acetic Acid (CAS: 25141-58-6): Recent Advances and Applications

2-Isopropylphenoxy acetic acid (CAS: 25141-58-6) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have highlighted its potential as a versatile intermediate in the synthesis of bioactive molecules and its emerging role in medicinal chemistry. This research brief synthesizes the latest findings on this compound, focusing on its synthetic applications, biological activities, and potential therapeutic uses.

A 2023 study published in the Journal of Medicinal Chemistry explored the use of 2-isopropylphenoxy acetic acid as a key building block for novel nonsteroidal anti-inflammatory drugs (NSAIDs). Researchers demonstrated that derivatives of this compound exhibited improved COX-2 selectivity compared to traditional NSAIDs, with reduced gastrointestinal side effects. The study particularly emphasized the importance of the isopropylphenoxy moiety in enhancing membrane permeability and target binding affinity.

In the realm of agrochemical research, a recent patent application (WO2023056789) disclosed novel herbicidal compositions containing 2-isopropylphenoxy acetic acid derivatives. The patent claims demonstrated superior weed control efficacy against broadleaf weeds while maintaining favorable environmental profiles. The mechanism of action appears to involve disruption of auxin-mediated growth processes in target plants.

Analytical chemistry advancements have also been made regarding this compound. A 2024 publication in Analytical and Bioanalytical Chemistry presented a highly sensitive LC-MS/MS method for quantifying 2-isopropylphenoxy acetic acid in biological matrices, achieving detection limits of 0.1 ng/mL. This methodological improvement facilitates more accurate pharmacokinetic studies of derivatives containing this structural motif.

From a structural perspective, computational chemistry studies have provided new insights into the conformational preferences of 2-isopropylphenoxy acetic acid. Molecular dynamics simulations published in Physical Chemistry Chemical Physics (2023) revealed that the isopropyl group significantly influences the rotational barrier of the phenoxy-acetic acid linkage, which has implications for drug design strategies utilizing this scaffold.

The safety profile of 2-isopropylphenoxy acetic acid has been recently evaluated in a comprehensive toxicological assessment (Regulatory Toxicology and Pharmacology, 2024). The compound demonstrated favorable acute toxicity parameters (LD50 > 2000 mg/kg in rodents) and showed no evidence of genotoxicity in standard battery tests, supporting its potential for further pharmaceutical development.

Ongoing research at several academic institutions is exploring the use of 2-isopropylphenoxy acetic acid as a precursor for radiopharmaceuticals. Preliminary results suggest that fluorine-18 labeled derivatives may serve as promising PET tracers for imaging inflammatory processes, with clinical trials expected to begin in 2025.

In conclusion, 2-isopropylphenoxy acetic acid (25141-58-6) continues to attract significant research attention across multiple disciplines. Its versatility as a synthetic intermediate, combined with emerging biological activities, positions this compound as an important focus area for future drug discovery and development efforts. Continued research is warranted to fully explore its therapeutic potential and optimize its applications in medicinal chemistry.

• 76343-98-1((2-sec-butylphenoxy)acetic Acid)
• 19271-90-0((2-tert-butylphenoxy)acetic Acid)
• 25141-45-1(2-(2-Benzylphenoxy)acetic Acid)
• 1798-03-4(2-(2-ethylphenoxy)acetic acid)
• 18327-79-2((2,4-Di-Tert-Butylphenoxy)Acetic Acid)
• 1643-16-9(2-[4-(propan-2-yl)phenoxy]acetic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)